Regeneron Pharmaceuticals, Inc.

Stocks

REGN

US75886F1075

Real-time Estimate Cboe BZX Other stock markets 03:10:45 2026-06-17 pm EDT			5-day change	1st Jan Change
607.61 ^USD	-1.16%		+1.19%	-21.13%

Jun. 11	Parabilis Medicines Closes Initial Public Offering	MT
Jun. 10	Parabilis Medicines to Raise $745 Million in IPO, Private Offering	MT

Transcript : Regeneron Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10

Published on 05/12/2026 at 04:50 pm EDT

S&P Capital IQ

Presenter Speech
Tazeen Ahmad (Analysts)

Thank you for joining us. Welcome back to the Bank of America Healthcare Conference. It's my pleasure to have with me our next presenting company, Regeneron

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Regeneron Pharmaceuticals, Inc.

Jun. 11	Parabilis Medicines Closes Initial Public Offering	MT
Jun. 10	Parabilis Medicines to Raise $745 Million in IPO, Private Offering	MT
Jun. 09	What Bundibugyo Ebola vaccines and treatments are under development	RE
Jun. 08	Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 02:00 PM
Jun. 04	What Bundibugyo Ebola vaccines and treatments are under development	RE
Jun. 03	CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise	MT
Jun. 03	CytomX Therapeutics, Inc. And Regeneron Pharmaceuticals, Inc. Expand Strategic Research Collaboration In The Field Of Conditional Bispecific Therapeutics For The Treatment Of Cancer	CI
May. 28	Regeneron Pharmaceuticals' Ebola Antibody Recommended by WHO for Investigational Use in Bundibugyo Ebolavirus	MT
May. 28	Regeneron's Ebola antibody recommended by World Health Organization for investigational use in response to current Bundibugyo ebolavirus outbreak	RE
May. 28	Regeneron Pharmaceuticals, Inc.'s Inmazeb And Maftivimab Recommended For Investigational Use In Bundibugyo Ebolavirus Outbreak	CI
May. 28	WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak	RE
May. 26	Wall Street Returns, Chips Lead
May. 26	US biotech Regeneron to launch global capability centre in India's Hyderabad - statement	RE
May. 22	Bundibugyo Ebola vaccines and treatments in development	RE
May. 22	Regeneron Says Otarmeni Application Accepted Under EU Accelerated Assessment	MT